HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Risperdal Long Acting Injectable Antipsychotic Medication

TERMINATED · · Psychotic Disorders

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.